Renal Dialysis Clinical Trial
Official title:
Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients
It is unknown whether Coronavirus disease 2019 vaccines confer the same high level of protection in patients with kidney disease as reported for participants in recent trials, who were generally healthy. Objectives: To evaluate the safety and efficacy of Coronavirus disease 2019 vaccines in hemodialysis patients.
Given the vulnerability of people with chronic kidney disease to Coronavirus 2019 , leading nephrology societies such as the National Kidney Federation and the American Kidney Foundation have issued statements calling for prioritization of these patients for vaccination. It is unknown whether Coronavirus disease 2019 vaccines confer the same high level of protection in patients with kidney disease as reported for participants in recent trials, who were generally healthy. Objectives: 1. Estimate the proportion of hemodialysis patients who present events supposedly attributed to vaccines and immunizations after having received a Coronavirus disease 2019 vaccine 2. Determine the levels of Immunoglobulin G antibodies in patients who received a Coronavirus disease 2019vaccine between the time before the first dose, at 21 days, at 40 days and at 120 days after immunization. Methods Design: Multicenter, observational and analytical study of a prospective cohort of hemodialysis patients 18 years and older who received immunization with a Coronavirus disease 2019 vaccine in the Autonomous City of Buenos Aires in a vaccination plan. Analysis The proportion of patients with Adverse events presumably attributable to vaccination and immunization will be estimated with its 95% confidence interval. The immunoglobulin G titer for coronavirus type 2 causing severe acute respiratory syndrome will be compared using Generalized Estimating Equations models. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05189795 -
The Construction of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
||
Completed |
NCT01125202 -
Intervention to Reduce Dietary Sodium in Hemodialysis
|
N/A | |
Completed |
NCT00753116 -
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
|
Phase 1 | |
Completed |
NCT00806130 -
Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients
|
||
Completed |
NCT00730145 -
A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis
|
Phase 1 | |
Completed |
NCT05718765 -
The Effect of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
|
N/A | |
Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
Completed |
NCT05469620 -
Adaptive Nutrition Therapy in Hemodialysis
|
N/A | |
Completed |
NCT03536858 -
Social Networks and Renal Education: Promoting Transplantation
|
N/A | |
Completed |
NCT00824837 -
Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane
|
Phase 1/Phase 2 | |
Completed |
NCT03403491 -
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
|
N/A | |
Terminated |
NCT02495662 -
The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation
|
Phase 2 | |
Completed |
NCT01179620 -
Certoparin in Renal Patients Undergoing Hemodialysis
|
Phase 3 | |
Completed |
NCT01017276 -
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
|
Phase 3 | |
Active, not recruiting |
NCT04466865 -
A Communication Tool to Assist Older Adults Facing Dialysis Choices
|
N/A | |
Recruiting |
NCT03782519 -
Quality of Life of Frail Aged Patients in Incremental Hemodialysis
|
N/A | |
Recruiting |
NCT02843334 -
Study of the Prevalence of Fabry Disease in French Dialysis Patients
|
N/A | |
Recruiting |
NCT02545530 -
Transdermal Clonidine in Chronic Hemodialysis Patients
|
N/A | |
Completed |
NCT00892749 -
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
|
Phase 3 | |
Completed |
NCT00649298 -
A Clinical Trial of IntensiVE Dialysis
|
Phase 4 |